OrigiMed Company
%20.jpg)
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, they identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aiming to fortify the evolution of cancer precision medicine in China.
%20.jpg)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
China
Founded Date:
42370
Last Funding Date:
2018-12-20
Total Funding:
$39M
Technology:
diagnostics
Employee Number:
251-500
Estimated Revenue:
Less than $1M
Investors Number:
5
Industry:
Health Care, Health Diagnostics